AI Article Synopsis
- The production of biopharmaceuticals in transgenic plants could lead to the emergence of a new industry that provides numerous benefits globally.
- The industry will likely need strict regulations, which may not be well-received by Japan or many developing nations.
- There is a suggestion for countries to utilize non-food crops for biopharmaceutical production and focus on simpler regulatory systems while promoting the advantages of these biopharmaceuticals both domestically and internationally.
Article Abstract
Production of biopharmaceuticals in transgenic plants would involve the creation of a new industry. Those transgenic plants, including staple food crops, could provide many benefits to people all over the world. However, the new industry might require a strict regulation system. It is probable that such a strict system would not be acceptable to Japan or to most developing countries. Many countries should use non-food crops for production of biopharmaceuticals and take on more simple systems. The new industry must develop strategies for promoting the benefits of transgenic plant-derived biopharmaceuticals on both the domestic and worldwide scales.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1517/14712598.4.10.1565 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!